 | About the cover
March 1999 - Vol 17 No 3
Nature Biotechnology 17 (1999)
| | |  | Structure of an engineered dimeric human ribonuclease (foreground) which has been altered to both facilitate targetting to cancer cells and to render it insensitive to its natural cytosolic inhibitor (shown in background). For more details, see Suzuki et al. p265 and Wagner and Lipovsek, p227 Illustration by Ken Eward (BioGrafx,Mount Vernon, Ohio).
|
|  |
|
